Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment

    Investment - Page 4

    Unilever CEO retires , replaced by insider Jope

    Unilever CEO retires , replaced by insider Jope

    Medical Dialogues Bureau1 Dec 2018 9:00 AM IST
    LONDON: Unilever's Chief Executive Paul Polman will step down next month after 10 years in the job, leaving insider Alan Jope to step into his shoes...
    Jubilant Life joins hand with Inipharm Inc for over Rs 199 crore

    Jubilant Life joins hand with Inipharm Inc for over Rs 199 crore

    Medical Dialogues Bureau30 Nov 2018 9:30 AM IST
    NEW DELHI: Drug firm Jubilant Life Sciences on Thursday said its subsidiary Drug Discovery and Development Solutions Ltd (DDDSL) Singapore has entered...
    Bayer to slash 12,000 jobs after Monsanto takeover

    Bayer to slash 12,000 jobs after Monsanto takeover

    Medical Dialogues Bureau30 Nov 2018 9:00 AM IST
    BERLIN: German chemical and pharmaceutical giant Bayer said Thursday it would slash 12,000 jobs in a major restructuring following the mammoth...
    GE Capital sells 1.5 billion dollar healthcare equipment portfolio to TIAA

    GE Capital sells 1.5 billion dollar healthcare equipment portfolio to TIAA

    Medical Dialogues Bureau19 Nov 2018 1:47 PM IST
    New Delhi: General Electric Co has recently announced its lending arm has sold a $1.5 billion healthcare equipment finance portfolio to U.S. lender...
    Make in Odisha:  government launches Rs 2750 Crore investment in Healthcare

    Make in Odisha: government launches Rs 2750 Crore investment in Healthcare

    Medical Dialogues Bureau16 Nov 2018 10:00 AM IST
    New Delhi: Odisha government has launched the Vision-2025 health care at the Make in Odisha Conclave 2018, the flagship biennial global investors'...
    Lilly to consider more acquisitions like Rs 115 Crore Armo buy

    Lilly to consider more acquisitions like Rs 115 Crore Armo buy

    Medical Dialogues Bureau9 Nov 2018 9:40 AM IST
    New Delhi: Eli Lilly and Co will consider more acquisitions similar to its $1.6 billion purchase of cancer drug developer Armo Biosciences earlier...
    Strides Pharma Science to get Rs 147 Crore funding for consumer healthcare business

    Strides Pharma Science to get Rs 147 Crore funding for consumer healthcare business

    Medical Dialogues Bureau2 Nov 2018 11:57 AM IST
    The agreement also envisages Strides Consumer Pvt Ltd to become a fully owned subsidiary of Strides Global Consumer Healthcare Ltd at a later date,...
    Eli Lilly buys Rs 736 Crore stake in gene-silencing drug firm Dicerna

    Eli Lilly buys Rs 736 Crore stake in gene-silencing drug firm Dicerna

    Medical Dialogues Bureau30 Oct 2018 4:43 PM IST
    Dicerna will receive an upfront payment of $100 million, as well as an equity investment of $100 million at a premium. New Delhi: Eli Lilly and...
    BRS Venture Plans to invest Rs 2193 crore to acquire Indian Hospitals

    BRS Venture Plans to invest Rs 2193 crore to acquire Indian Hospitals

    Medical Dialogues Bureau28 Oct 2018 9:15 AM IST
    New Delhi: The UAE-based USD 3 billion BRS Ventures plans to acquire hospitals in India, as it looks to consolidate its healthcare practice. BRS...
    Manipal eyes Medanta, Sets Valuation at Rs 6000 crore: Report

    Manipal eyes Medanta, Sets Valuation at Rs 6000 crore: Report

    Garima25 Oct 2018 5:47 PM IST
    Mumbai: After facing a setback with the lost Fortis bid, the healthcare giant, TPG Capital and Manipal Health Enterprises combine, is leaving no stone...
    J&J offers 2.1 billion dollars to acquire Japan Cosmetics firm Ci:z

    J&J offers 2.1 billion dollars to acquire Japan Cosmetics firm Ci:z

    Medical Dialogues Bureau24 Oct 2018 1:00 PM IST
    TOKYO: U.S. healthcare conglomerate Johnson & Johnson had recently announced that it will buy all outstanding shares of Japanese skincare firm...
    Dr Reddys finalises deal to sell Hyderabad API unit to Therapiva

    Dr Reddy's finalises deal to sell Hyderabad API unit to Therapiva

    Medical Dialogues Bureau16 Oct 2018 1:46 PM IST
    New Delhi: Drug major Dr Reddy's Laboratories (DRL) Monday said it will sell its active pharmaceutical ingredient (API) business unit in Hyderabad to...
    PrevNext

    Popular Stories

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    India should become self-reliant in medical equipment, devices: Kasturirangan

    India should become self-reliant in medical equipment, devices: Kasturirangan

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Lasa Supergenerics gets FDA nod for Progesterone

    Lasa Supergenerics gets FDA nod for Progesterone

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok